News

At AAO, Kamran Riaz, MD, discussed the new textbook, "Optics for the New Millennium," which is intended to be a compendium resource for ophthalmologists.

LENZ Therapeutics has unveiled positive topline data from its INSIGHT study achieved by 2 formulations to treat presbyopia.

Harvey Uy, MD, has been using the Ally adaptive cataract treatment system at his clinic in the Philippines, and it is allowing him to be more efficient.

Lisa M. Nijm, MD, JD, shares highlights from the Real World Ophthalmology 'After Dark' networking reception held at the American Academy of Ophthalmology annual meeting. The next Real World Ophthalmology meeting on November 5—which will be virtual—will cover important clinical, business, and personal growth areas for young ophthalmologists.

According to a BBC News report, the woman showered while wearing her lenses and she contracted a rare parasite infection called Acanthamoeba keratitis.

According to a news release, Oculis officials hope to forward product candidates to address areas of significant medical needs, including diabetic macular edema, dry eye disease, and neuro-retina indications such as glaucoma, affecting growing patient populations.

Baseline age, best-corrected visual acuity, and central subfield thickness play role in predicting the efficacy of both drugs.

According to Thomas Aaberg, MR, the novel therapy is geared to treat rare, debilitating eye disease.

Results from our recent poll indicate that many ophthalmologists (63%) plan to use biosimilars in their clinical practice.

According to a news release, Eyenuk will use the capital to expand its AI product platform with additional disease indications and advanced care coordination, and to accelerate the platform’s global commercialization and adoption.

According to the company, latanoprost ophthalmic solution 0.005% successfully met the primary and all secondary endpoints, and it plans to file an NDA with the FDA in Q1 2023.

Anterior segment surgeon expands on the use of the XtraFocus pinhole implant.

The therapy may offer novel treatment strategy with unique mechanism, modality for patients diagnosed with dry age-related macular degeneration.

A California ophthalmologist posted a video of a procedure she performed to remove 23 contact lenses from a woman’s eye, and the video has gone viral, with more than 1 million views.

On this week's episode of the NeuroOp Guru, Andy Lee, MD, and Elizabeth Fortin, MD, compare the 1.5 Tesla magnet and the 3.0 Tesla magnet for MRI.

Kathryn A. Colby, MD, PhD, discusses highlights of the World Cornea Congress, which was held recently in Chicago.

According to Michael E. Snyder, MD, the pars plana anterior vitrectomy offers more advantages than disadvantages and can be readily adopted by anterior segment surgeons.

Chinese investigators found that obesity affects retinal structures in different ways depending on whether the obesity is generalized or abdominal.

Mike Lyons, PHR, MHRIR, and Megan Odell, BHA, MHHR, with Austin Retina Associates, outline how to implement the GREAT and the LEAP method for an improved employee and patient experience.

According to University of California, Irvine researchers, current preclinical successes and clinical genome editing approaches for treating inherited retinal degenerative disease and stresses there is hope that in vivo gene editing will be the future treatment paradigm for these diseases.

With World Sight Day upon us, RestoringVision has issued a lofty but doable goal: to help solve the global vision crisis.

Hear how ophthalmologists and optometrists in the United States are recognizing the importance of this year's awareness day.

NovaSight’s CureSight is a digital device that proved in a pivotal study to be non-inferior to patching, according to the company.

The training will overlap with World Sight Day, which spotlights the importance of eye care. Orbis's clinical staff and medical experts along with UC Davis Medical Health physicians and staff will share their knowledge with nearly 50 ophthalmologists, ophthalmology residents, nurses, and biomedical engineers from Bolivia, Chile, and Peru.

Nanoscope Therapeutics Inc. announced the FDA has granted Fast Track Designation to MCO-010, an ambient-light activatable multi-characteristic opsin optogenetic monotherapy to restore vision in blind patients, for the treatment of retinitis pigmentosa via intravitreal injection.

According to a study, vision loss and depression are common conditions with major health implications, but exactly why this association occurs remains a mystery.

According to a study by researchers at the Scheie Eye Institute in the Perelman School of Medicine at the University of Pennsylvania, patients’ low-light sensitivity improved by factors of thousands in a clinical trial.

Donny W. Suh, MD, finds his love for practicing pediatric ophthalmology grows stronger with each passing year. He offers two tips to fellow physicians and his residents and fellows for managing the stressors of daily practice and for getting a good night’s sleep. He also shares his journey in a book called “Catching A Star,” with all proceeds going to a medical mission program.